$29.54 meals Payment -- Johnson & Johnson to Dr. Kevin Hill

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

This report analyzes a payment of $29.54 from Johnson & Johnson to Dr. Kevin Hill, a General Surgeon, on June 12, 2024. The payment was for meals (Food and Beverage) related to the drug Kisqali. Is this amount typical? For a meal, $29.54 is a modest amount. While some meals can be more expensive, especially if they involve educational components or multiple attendees, this figure suggests a relatively small expenditure, perhaps a single meal or a coffee break. For general surgery, which often involves complex procedures and a wide range of medications and devices, such small meal payments are not uncommon. Many physicians in various specialties receive similar or larger payments for meals, often during educational events or when discussing specific treatments with pharmaceutical representatives. Potential conflict of interest considerations are minimal with this specific payment. The Sunshine Act requires reporting of payments exceeding $10 (adjusted annually for inflation), so this $29.54 meal is reportable. However, the low dollar amount and the nature of the payment (food and beverage) make a significant conflict of interest unlikely. The primary concern with larger or more frequent payments is whether they might unduly influence a physician's prescribing habits or treatment recommendations. A single meal of this value is unlikely to sway clinical judgment. Industry averages for payments to physicians vary widely by specialty, drug, and type of payment. General surgeons, like other specialists, can receive payments for speaking, consulting, research, travel, and meals. While specific averages for meal payments to general surgeons are not readily available in this format, this $29.54 payment is likely on the lower end of reported meal expenditures. Many physicians receive no payments, while others receive substantial amounts over time. This single, small payment is unlikely to place Dr. Hill significantly above or below any typical payment profile for his specialty, especially when considering all payment types. What patients should understand is that the Sunshine Act aims to provide transparency. This payment is publicly available information. While it's important to be aware of these relationships, a single, small meal payment like this does not automatically mean your doctor's decisions are compromised. It signifies an interaction with the pharmaceutical industry, which is common. The key is to consider the totality of payments and the nature of the interactions. For patients, understanding that these interactions occur and knowing how to access this information empowers them to have informed conversations with their doctors about treatment options and potential influences.

Patient Guidance: What This Payment Means for You

It's understandable to be curious about payments your doctor receives from pharmaceutical companies. The Sunshine Act makes this information public, and this $29.54 meal payment from Johnson & Johnson to Dr. Hill is an example. When considering these payments, remember that the amount and type matter. A small meal payment like this is generally considered routine interaction, often occurring during educational events or discussions about medications like Kisqali. It's unlikely to significantly influence medical decisions. However, if you have concerns, you can always ask your doctor directly. A good approach is to say, 'I saw that you received a small meal payment from Johnson & Johnson. Can you tell me more about that interaction and how it relates to my care?' This opens a dialogue without being accusatory. Focus on your overall trust in your doctor's judgment. While transparency is important, don't let small, reported payments overshadow the quality of care you receive. If you notice a pattern of large or frequent payments, or if your doctor seems overly focused on a specific drug without clear clinical justification, that might be a reason for deeper inquiry. For most patients, understanding that these interactions exist and that the system aims for transparency is sufficient.

Payment Context: Is This Amount Normal?

Payments for meals and beverages to physicians are common across many specialties, including General Surgery. While specific averages for meal payments alone are hard to isolate, the $29.54 amount is modest. Many physicians in General Surgery, like those in other fields, may receive such payments, particularly if they attend industry-sponsored educational events or meet with pharmaceutical representatives. The percentage of doctors receiving payments varies, but a significant portion of physicians interact with the industry in some capacity.

Regulatory Context: Sunshine Act Requirements

Under the Sunshine Act (part of the Affordable Care Act), pharmaceutical companies and medical device manufacturers must report payments and other transfers of value made to physicians and teaching hospitals. Payments exceeding a de minimis threshold (currently $10, adjusted annually) must be reported. This $29.54 meal payment clearly meets the reporting requirement. These types of routine meal payments are generally subject to standard reporting and do not typically face special scrutiny unless they are part of a larger pattern of concerning interactions.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharma-payments
• general-surgery
• sunshine-act
• conflict-of-interest
• kisqali
• johnson-and-johnson
• meals-and-beverages

Understanding meals Payments

Food and beverage payments cover meals provided to physicians during pharmaceutical sales representative visits, medical conferences, and educational events. While individual meal payments tend to be small (often under $100), research published in JAMA Internal Medicine has shown that even modest meals can be associated with changes in prescribing behavior. Meal payments are the most common type of pharmaceutical payment to physicians.

Frequently Asked Questions About This Payment

Does my doctor take pharma money?

You can check if your doctor receives payments from pharmaceutical or medical device companies through the Centers for Medicare & Medicaid Services (CMS) Open Payments database. Simply search for your doctor's name or National Provider Identifier (NPI). The database lists reported payments, including the company, amount, date, and nature of the payment (e.g., meals, consulting fees, speaking fees). Seeing that a doctor receives payments doesn't automatically mean their care is compromised. It's a transparency measure. Many physicians have relationships with the industry, and the significance depends on the type and amount of payments.

Should I worry about this payment?

For this specific payment of $29.54 for a meal from Johnson & Johnson to Dr. Hill, it's generally not a cause for significant concern. The amount is small, and meals are a common form of interaction between physicians and pharmaceutical companies, often related to educational purposes or discussions about specific drugs like Kisqali. The Sunshine Act requires reporting even small payments to ensure transparency. Unless you observe a pattern of frequent or large payments, or if your doctor's prescribing habits seem unusual or overly influenced by a particular drug, a single meal payment of this nature is typically considered routine.

What types of pharma payments are most concerning?

While any payment warrants transparency, certain types of pharmaceutical payments tend to raise more concern regarding potential conflicts of interest. These include large consulting fees, significant speaking fees (especially for 'educational' events that primarily promote a drug), substantial research grants, or payments for travel and lodging to conferences where the primary purpose seems to be marketing. Payments for meals, while reportable, are generally considered less influential due to their lower value. The frequency and totality of payments also matter; a pattern of numerous or substantial payments across different categories is more noteworthy than isolated, small transactions.

How do I talk to my doctor about pharma relationships?

Approach the conversation with curiosity and a desire for understanding, not accusation. You could start by saying, 'I've been looking at the Open Payments database and saw that you received a payment from [Company Name] for [Type of Payment]. Could you tell me more about that?' Or, 'I'm interested in understanding how you stay updated on new medications. Do you interact with pharmaceutical representatives?' Ask specific questions like: 'How does this relationship inform your prescribing decisions?' or 'Are there alternative treatments available?' The goal is to foster open communication about how your doctor stays informed and makes treatment recommendations.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for doctors to accept payments from pharmaceutical and medical device companies, provided these relationships are transparent and comply with regulations like the Sunshine Act. The Sunshine Act requires companies to report most payments made to physicians and teaching hospitals, which are then made public. This transparency is intended to help patients and the public understand potential influences on medical decision-making. Doctors can legally receive payments for legitimate activities such as consulting, speaking, research, and education, but these must be accurately reported.

Does pharma money affect what my doctor prescribes?

Research suggests that interactions with the pharmaceutical industry, including receiving payments, can influence physicians' prescribing habits. Even small interactions, like receiving meals, have been linked to increased prescribing of the sponsoring company's drugs. However, the extent of this influence varies greatly among physicians and depends on the type, frequency, and amount of payments. Many physicians maintain their independence, but awareness of these potential influences is crucial for both patients and doctors. Transparency through the Sunshine Act aims to mitigate undue influence by making these relationships visible.

How does this compare to other doctors in this specialty?

This specific payment of $29.54 for a meal is a relatively small amount. While many physicians in General Surgery, like in other specialties, may receive payments for various reasons (consulting, speaking, meals, etc.), this particular transaction is modest. It's difficult to provide an exact comparison without analyzing the full payment history for Dr. Hill and comparing it to the average for all General Surgeons. However, this single meal payment is unlikely to place him significantly above or below the typical range of interactions, especially when considering that many physicians receive no payments at all, while others receive substantial amounts over time.

Related Reports

• View Dr. Kevin Hill's full payment report
• Johnson & Johnson full spending report
• Browse all General Surgery payments
• Browse all payments in Virginia
• Search for other payments